Compare NKTX & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTX | PDEX |
|---|---|---|
| Founded | 2015 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.9M | 189.2M |
| IPO Year | 2020 | 1995 |
| Metric | NKTX | PDEX |
|---|---|---|
| Price | $3.14 | $65.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $11.33 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 749.2K | 18.4K |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.88 | ★ 345.00 |
| EPS | N/A | ★ 3.27 |
| Revenue | N/A | ★ $66,593,000.00 |
| Revenue This Year | N/A | $7.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.40 |
| Revenue Growth | N/A | ★ 23.68 |
| 52 Week Low | $1.63 | $23.52 |
| 52 Week High | $3.65 | $64.69 |
| Indicator | NKTX | PDEX |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 72.84 |
| Support Level | $1.88 | $37.43 |
| Resistance Level | $3.35 | N/A |
| Average True Range (ATR) | 0.21 | 2.67 |
| MACD | -0.01 | 0.66 |
| Stochastic Oscillator | 74.00 | 100.00 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.